29
Fri, Mar
48 New Articles

TGS Baltic Defends Grindeks Shareholders Against EUR 2 Million Claim

TGS Baltic Defends Grindeks Shareholders Against EUR 2 Million Claim

Latvia
Tools
Typography
  • Smaller Small Medium Big Bigger
  • Default Helvetica Segoe Georgia Times

TGS Baltic has successfully represented the shareholders of the AS Grindeks pharmaceutical company in Latvia's appellate court against a EUR 1,903,294.80 damages claim by VAS Privatizacijas Agentura arising from Grindeks' failure to make an allegedly mandatory buy-back offer.

TGS Baltic’s team consisted of Partners Ivars Grunte and Nauris Grigals.

According to TGS Baltic, the appellate court's ruling remains subject to "appeal in the high court senate."

Our Latest Issue